A novel rat lipoxin A4 receptor that is conserved in structure and function. - Wikidata - awgldk - TriplyDB

A novel rat lipoxin A4 receptor that is conserved in structure and function.

A novel rat lipoxin A4 receptor that is conserved in structure and function.

http://www.wikidata.org/entity/Q35045249

about

DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32 Annexin A1 regulates intestinal mucosal injury, inflammation, and repair Resolution of acute inflammation in the lung Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.Novel anti-inflammatory--pro-resolving mediators and their receptors 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells Resolution of inflammation in periodontitis Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma.Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor Lipoxin A4 Reduces Inflammation Through Formyl Peptide Receptor 2/p38 MAPK Signaling Pathway in Subarachnoid Hemorrhage Rats.Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection.Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion Lipoxins: resolutionary road.Natural resolution of inflammation.Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.

P2860

Q28269550-A4D9E548-F7E1-4B56-892B-C5B38E7A140D Q28274076-1E1EB98F-001E-48FC-9C78-28C533933390 Q28594440-C5C80DB1-BAE6-44B5-8464-5FD30F3ED4F5 Q28652204-5B57044B-33B5-447B-A0B4-0930D9E2909F Q28716294-9795659E-DCBE-4234-9BBE-9B064C25D77C Q30514238-B8D16595-292A-41A2-ABE3-A2AB70FFC946 Q31134484-556ADC07-3E96-4357-BA25-D1CA414E9245 Q33384350-8239A1E9-EBB8-4346-A0EE-943E19266608 Q34982051-693DF987-7516-4FF6-9246-38E98EE35666 Q35126717-5B7D42D4-5E04-476F-B105-7DFAD0881ED1 Q35184153-7D8C72E0-3C74-4113-B574-2402334C507F Q36309261-55729790-875F-4860-B1DF-D3F3DDF3C19C Q36390428-565A5115-A5E4-420A-9266-CEEDC5028EF1 Q36485064-DF590FA0-6748-4FCC-A61F-FB380F2758DC Q36510408-86DF37AC-9C0D-4733-9C1D-346F393E3EB4 Q36783527-AE0E612F-6D58-4DE1-81F6-60B4BA2236BC Q37338329-6BDC260B-931A-4B57-ACD4-3BAE20CC09C8 Q37604436-589EC311-AFC6-4CB6-A079-EBCF562FDB4E Q38127782-EB027F5D-901E-4C0C-AC2D-E156B903983A Q39024419-61956F2F-6F44-4F91-94AB-AC379BAE090E Q41971303-98AE423E-AF59-43C2-AEA3-E13E29FADE0C Q42693504-8BF91D80-0410-4275-A5E2-080BB679D70D

P2860

A novel rat lipoxin A4 receptor that is conserved in structure and function.

http://www.wikidata.org/entity/Q35045249

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

A novel rat lipoxin A4 receptor that is conserved in structure and function.

@en

type

label

A novel rat lipoxin A4 receptor that is conserved in structure and function.

@en

prefLabel

A novel rat lipoxin A4 receptor that is conserved in structure and function.

@en

P1433

Q35045249-E310B3D0-7808-4DDA-9B92-C994BD165DA7

P1476

Q35045249-37AAA705-0898-4AE5-8E7F-1CD1DB16E4C7

P2093

Q35045249-16ABED6A-A2A4-4799-94F9-3A4D08F142B1

Q35045249-509EE05A-6661-4724-8523-C06036CF4702

Q35045249-815A9069-0380-42B7-95BB-564DA036098D

Q35045249-A5D4134E-AF31-437C-A6BB-3804276D7247

Q35045249-B0B732C9-9941-4FE0-AD6B-4E437428A9C5

P2860

Q35045249-01C489A0-3C50-43B3-8D33-9DC0895E7C03

Q35045249-0FA42C32-31F7-490A-944F-6ACE5307BD2A

Q35045249-2ADBD91B-4D3D-4748-83C8-B9BD10E5FA07

Q35045249-36A37DAA-BC24-4F06-9E3D-5633F2AA0305

Q35045249-3F7C0B9D-70F3-4A84-9B19-EEA8931544D4

Q35045249-4D6A3F05-65C3-46D4-85C2-0E5B1F4E2885

Q35045249-4FAA0F34-5DE9-4BAE-9ED3-111F0447360D

Q35045249-532426FE-454B-48F5-B489-59741325C117

Q35045249-54737CDA-D78C-48B5-91FE-63DF1E9612A7

Q35045249-5D4D1EE5-ED0C-44A0-B589-2EFA78DBF981

P304

Q35045249-AAFDE5B8-420F-49FD-8E6C-3794C37AE0D3

P31

Q35045249-FA7DDE78-3C73-42D1-A76F-3A91EF2313D9

P356

Q35045249-B1367F12-4DC8-4600-9A9F-F8743557AC38

P407

Q35045249-E31A4D2D-ECF1-40CF-B452-5A6072E7CFD3

P433

Q35045249-F683559F-3599-4207-A347-5AEFC8780559

P478

Q35045249-B9821505-90A7-41B9-95D3-D8DF003E6E98

P577

Q35045249-7D31822F-B634-404C-A7BD-83E778F9ADDD

P5875

Q35045249-5CDB844E-1267-4AE7-A62D-0B0096EB6EDE

P698

Q35045249-7A58393A-67F8-49FA-A777-B32A9B1C255A

P932

Q35045249-EEC93552-38CE-415D-B92A-2F89EB6C1339

P356

P1433

British Journal of Pharmacology

P1476

A novel rat lipoxin A4 receptor that is conserved in structure and function.

@en

P2093

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Makoto Arita

http://www.w3.org/2001/XMLSchema#string

Nan Chiang

http://www.w3.org/2001/XMLSchema#string

Shiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Tomoko Takano

http://www.w3.org/2001/XMLSchema#string

P2860

Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors

Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins

P304

89-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0705220

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10761047

http://www.w3.org/2001/XMLSchema#string

P698

12746227

http://www.w3.org/2001/XMLSchema#string

P932

1573822

http://www.w3.org/2001/XMLSchema#string